🚨NEW STUDY: High-Dose Vitamin C Is a Potent Anti-Cancer Agent
DECADES of evidence reveal that vitamin C attacks cancer through four powerful mechanisms: pro-oxidative cytotoxicity, epigenetic reprogramming, signaling-pathway suppression, and immune activation.
A MASSIVE new paper in Genes & Diseases analyzed 150+ studies and found that when vitamin C reaches true pharmacologic levels (20–30 mM), it behaves like a targeted, tumor-selective therapy — something past trials missed by under-dosing.
A MASSIVE new paper in Genes & Diseases analyzed 150+ studies and found that when vitamin C reaches true pharmacologic levels (20–30 mM), it behaves like a targeted, tumor-selective therapy — something past trials missed by under-dosing.
The evidence base spans decades of laboratory, animal, and early-phase clinical research.
✅ Human trials already show real benefits — pancreatic tumor shrinkage, longer survival in glioblastoma, higher response rates in lung cancer, and lower chemo toxicity.
✅ Effective dosing is high: 75–100 g IV (or >1 g/kg), 2–3× per week — the level required to hit the true cancer-killing range.
Bottom line: High-dose IV vitamin C is a multi-mechanism, tumor-targeting anti-cancer therapy that has been underestimated for decades — and now deserves modern Phase III trials.
